The First Line of Defense: Application of Breast Cancer Genomics Standards in Primary Care 

On Friday, February 21, 2014, the Georgia Breast Cancer Genomic Health Consortium will host a conference titled “The First Line of Defense: Application of Breast Cancer Genomic Standards in Primary Care” at the Lodge and Spa at Callaway Gardens.

The purpose of this conference is to enhance the knowledge of primary care providers on cancer genomics and genetic risk assessment, particularly Hereditary Breast and Ovarian Cancer syndrome (HBOC).

Register Now!                            This activity has been approved for 4.5 AMA PRA Category 1 credits. TM

This continuing nursing education activity was approved by the Georgia Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Click HERE to view the current draft of the conference program.

 

Jointly sponsored by the Morehouse School of Medicine and The Georgia Breast Cancer Genomic Health Consortium.

  

 

Due to the dynamic nature of the genetics field, it is challenging for health care providers to consistently incorporate new advancements into existing medical practice. Primary health care providers are in need of education that enables them to (a) appropriately identify personal and family cancer histories that indicate risk for a hereditary cancer syndrome; (b) gain an improved understanding of what hereditary cancer risk factors are; and (c) develop an awareness of tools and resources available to maximize the benefits of evidence-based, preventive cancer care for those with a genetic risk.

Conference Objectives:

• Identify patients at risk for HBOC through the recognition of one family history red flags.

• Organize the steps of cancer genetic counseling and testing and referral process for HBOC.

• Explain the three possible test results of genetic testing for hereditary breast cancer.

• Identify one agency that provides genetic testing and counseling guidelines.

• Locate at least two appropriate resources for patients at risk for Hereditary Breast and Ovarian Cancer syndrome.